BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21976627)

  • 1. Electronic portal imaging vs kilovoltage imaging in fiducial marker image-guided radiotherapy for prostate cancer: an analysis of set-up uncertainties.
    Gill S; Thomas J; Fox C; Kron T; Thompson A; Chander S; Williams S; Tai KH; Duchesne G; Foroudi F
    Br J Radiol; 2012 Feb; 85(1010):176-82. PubMed ID: 21976627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost minimisation analysis: kilovoltage imaging with automated repositioning versus electronic portal imaging in image-guided radiotherapy for prostate cancer.
    Gill S; Younie S; Rolfo A; Thomas J; Siva S; Fox C; Kron T; Phillips D; Tai KH; Foroudi F
    Clin Oncol (R Coll Radiol); 2012 Oct; 24(8):e93-9. PubMed ID: 22694787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential failure risk of the cone-beam computed tomography-based planning target volume margin definition for prostate image-guided radiotherapy based on a prospective single-institutional hybrid analysis.
    Hirose K; Sato M; Hatayama Y; Kawaguchi H; Komai F; Sohma M; Obara H; Suzuki M; Tanaka M; Fujioka I; Ichise K; Takai Y; Aoki M
    Radiat Oncol; 2018 Jun; 13(1):106. PubMed ID: 29880006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptive radiotherapy and the dosimetric impact of inter- and intrafractional motion on the planning target volume for prostate cancer patients.
    Böckelmann F; Putz F; Kallis K; Lettmaier S; Fietkau R; Bert C
    Strahlenther Onkol; 2020 Jul; 196(7):647-656. PubMed ID: 32157345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of daily online set-up errors and organ displacement uncertainty during conformal radiation treatment of the prostate.
    Osei EK; Jiang R; Barnett R; Fleming K; Panjwani D
    Br J Radiol; 2009 Jan; 82(973):49-61. PubMed ID: 18955413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Residual seminal vesicle displacement in marker-based image-guided radiotherapy for prostate cancer and the impact on margin design.
    Smitsmans MH; de Bois J; Sonke JJ; Catton CN; Jaffray DA; Lebesque JV; van Herk M
    Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):590-6. PubMed ID: 20888710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Image-guided radiotherapy (IGRT) for prostate cancer comparing kV imaging of fiducial markers with cone beam computed tomography (CBCT).
    Barney BM; Lee RJ; Handrahan D; Welsh KT; Cook JT; Sause WT
    Int J Radiat Oncol Biol Phys; 2011 May; 80(1):301-5. PubMed ID: 20864274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Image-guided radiotherapy for prostate cancer using 3 different techniques: localization data of 186 patients.
    Garibaldi C; Jereczek-Fossa BA; Zerini D; Cambria R; Ferrari A; Serafini F; Cattani F; Tagaste B; Fodor C; Luraschi R; Orecchia R
    Tumori; 2015; 101(3):273-80. PubMed ID: 25908027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tracking target position variability using intraprostatic fiducial markers and electronic portal imaging in prostate cancer radiotherapy.
    Munoz F; Fiandra C; Franco P; Guarneri A; Ciammella P; De Stefanis P; Rondi N; Moretto F; Badellino S; Iftode C; Ragona R; Ricardi U
    Radiol Med; 2012 Sep; 117(6):1057-70. PubMed ID: 22327924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interfraction prostate displacement during image-guided radiotherapy using intraprostatic fiducial markers and a cone-beam computed tomography system: A volumetric off-line analysis in relation to the variations of rectal and bladder volumes.
    Ingrosso G; Miceli R; Ponti E; Lancia A; di Cristino D; de Pasquale F; Bove P; Santoni R
    J Cancer Res Ther; 2019 Mar; 15(Supplement):S69-S75. PubMed ID: 30900624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of in-room computerized tomography options for detection of fiducial markers in prostate cancer radiotherapy.
    Owen R; Foroudi F; Kron T; Milner A; Cox J; Cramb J; Zhu L; Duchesne G
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1248-56. PubMed ID: 20610045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of CT on rails with electronic portal imaging for positioning of prostate cancer patients with implanted fiducial markers.
    Owen R; Kron T; Foroudi F; Milner A; Cox J; Duchesne G; Cleeve L; Zhu L; Cramb J; Sparks L; Laferlita M
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):906-12. PubMed ID: 19480970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of the three degrees-of-freedom fiducial marker-based setup compared to soft tissue-based setup in hypofractionated intensity-modulated radiotherapy for prostate cancer.
    Tanabe S; Utsunomiya S; Abe E; Sato H; Ohta A; Sakai H; Yamada T; Kaidu M; Aoyama H
    J Appl Clin Med Phys; 2019 Jun; 20(6):53-59. PubMed ID: 31054217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification and predictors of prostate position variability in 50 patients evaluated with multiple CT scans during conformal radiotherapy.
    Zelefsky MJ; Crean D; Mageras GS; Lyass O; Happersett L; Ling CC; Leibel SA; Fuks Z; Bull S; Kooy HM; van Herk M; Kutcher GJ
    Radiother Oncol; 1999 Feb; 50(2):225-34. PubMed ID: 10368047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization accuracy of two electromagnetic tracking systems in prostate cancer radiotherapy: A comparison with fiducial marker based kilovoltage imaging.
    Vanhanen A; Syrén H; Kapanen M
    Phys Med; 2018 Dec; 56():10-18. PubMed ID: 30527084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observer uncertainties of soft tissue-based patient positioning in IGRT.
    Hirose TA; Arimura H; Fukunaga JI; Ohga S; Yoshitake T; Shioyama Y
    J Appl Clin Med Phys; 2020 Feb; 21(2):73-81. PubMed ID: 31957964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does Interfraction Cone Beam Computed Tomography Improve Target Localization in Prostate Bed Radiotherapy?
    Elakshar S; Tsui JMG; Kucharczyk MJ; Tomic N; Fawaz ZS; Bahoric B; Papayanatos J; Chaddad A; Niazi T
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819831962. PubMed ID: 30782085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Image-guided intensity-modulated radiotherapy of prostate cancer: Analysis of interfractional errors and acute toxicity.
    Rudat V; Nour A; Hammoud M; Alaradi A; Mohammed A
    Strahlenther Onkol; 2016 Feb; 192(2):109-17. PubMed ID: 26545764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTV margin definition in hypofractionated IGRT of localized prostate cancer using cone beam CT and orthogonal image pairs with fiducial markers.
    Oehler C; Lang S; Dimmerling P; Bolesch C; Kloeck S; Tini A; Glanzmann C; Najafi Y; Studer G; Zwahlen DR
    Radiat Oncol; 2014 Nov; 9():229. PubMed ID: 25384898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interfraction rotation of the prostate as evaluated by kilovoltage X-ray fiducial marker imaging in intensity-modulated radiotherapy of localized prostate cancer.
    Graf R; Boehmer D; Budach V; Wust P
    Med Dosim; 2012; 37(4):396-400. PubMed ID: 22534137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.